Pfizer pill

The Pfizer experimental pill reduces risk of hospitalization, death from Covid-19

Drug maker Pfizer said Friday they have designed experimental pill to fight Corona-virus reduced the risk of hospitalization and death for high-risk patients taking part in a trial of the drug.

The specialists of the company hopes it can eventually offer the pill, given in combination with an older antiviral drug called Ritonavir, to people to take at home/work before they get sick enough to go to the hospital.A so-called interim analysis — done before the trial was scheduled to end — showed about 89% reduction in the risk of hospitalization or death from Covid-19 if patients got it soon enough.

The company has been testing the drug in adults with Covid-19 who are considered at high risk of progressing to severe sickness. The volunteers have been randomly given either the pill combination or a placebo within three days to five days of their symptoms starting.

Add your comment

Your email address will not be published.